Navigation Links
Global Healthcare, Regulatory and Reimbursement Landscape Forecasts and Trends in UAE, Canada and Taiwan
Date:11/26/2012

FARMINGTON, Conn., Nov. 26, 2012 /PRNewswire-iReach/ -- The healthcare system in the United Arab Emirates is characterized by high public expenditure on implementation of healthcare policies and expanding private infrastructure to offer more sophisticated facilities. Taiwan's healthcare system is characterized by three positive trends: a growing elderly population, universal healthcare insurance, and a high degree of access to healthcare facilities. In Canada, government initiatives for the prevention and management of chronic diseases in addition to strong, efficient, and transparent guidelines that simplify the regulatory process differentiate the positive trends in the Canadian healthcare market.

(Photo: http://photos.prnewswire.com/prnh/20121126/CG18486)

Global Information Inc (GII) is pleased to present three market research reports covering the healthcare, regulatory and reimbursement market landscapes in the UAE, Canada, and Taiwan from our premium research partner, GlobalData.

Healthcare, Regulatory and Reimbursement Landscape - United Arab Emirates

The UAE is the second largest country in the Middle East in terms of capital invested in the pharmaceutical sector. Its pharmaceutical market was worth $1 billion in 2006 and is estimated to reach approximately $3.7 billion by 2020 at a Compound Annual Growth Rate (CAGR) of 9.8% (Kulkarni, 2010). The growing popularity of medical tourism is the main contributor to market growth, as well as factors such as the growing elderly population.

The medical device market in the UAE was worth approximately $541.1m in 2006 and is estimated to reach $979m by 2020 at a CAGR of 4.3%. Key growth drivers of UAE's medical device market are increasing public and private wealth fuelled by the oil boom, the absence of significant local competition and a strong and growing healthcare infrastructure.

This report will benefit executives by explaining the trends shaping and driving the healthcare market in United Arab Emirates to help them develop better business strategies, drive revenues, formulate effective sales and marketing plans, and identify, understand and capitalize on the opportunities and challenges in the healthcare market.

An Executive Summary for this report and free sample pages from the full document are available at http://www.giiresearch.com/report/gd254866-healthcare-regulatory-reimbursement-landscape.html

Healthcare, Regulatory and Reimbursement Landscape – Canada

Canada's population was approximately 34.4 million in 2011, and is growing largely as a result of immigration. The natural growth rate of the population is projected to be low due to the balance between the mortality and birth rates. The increasing elderly population, however, is a matter of concern for policy planners.

According to the report, the pharmaceutical market in Canada was valued at about $21.5 billion in 2010 and is expected to reach approximately $45.9 billion by 2020, at a projected 9.9% CAGR. The medical device market was valued at approximately $7.7 billion in 2011 and is expected to reach approximately $12.2 billion by 2020, at a projected 5.2% CAGR.

This report identifies key trends in the Canadian healthcare market, and also provides insights on the demographic, regulatory, and reimbursement landscape, as well as the healthcare infrastructure. Most importantly, the report provides valuable insights on the trends and segmentation of the pharmaceutical and medical devices markets.

An Executive Summary for this report and free sample pages from the full document are available at http://www.giiresearch.com/report/gd251028-healthcare-regulatory-reimbursement-landscape.html

Healthcare, Regulatory and Reimbursement Landscape – Taiwan

The market for medical devices in Taiwan is one of the largest in Asia. It was valued at approximately $1.6 billion in 2006 and grew at a CAGR of 5.1% to $1.9 billion in 2011. It is predicted to reach $3 billion by 2020.

The scope of this report includes: an overview of Taiwan's pharmaceutical and medical device markets; profiles and SWOT analyses of major players in the pharmaceutical and medical device markets; review of the reimbursement and regulatory landscape; detailed analysis of Taiwan's political and economic environment; and an overview of the opportunities and challenges.

An Executive Summary for this report and free sample pages from the full document are available at http://www.giiresearch.com/report/gd250471-healthcare-regulatory-reimbursement-landscape.html

About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Jeremy Palaia Global Information, Inc., 1-860-674-8796, Press@gii.co.jp

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Global Information, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmaceutical Market Fails to Capture $188 Billion U.S. Revenue and $564 Billion Global Revenue Annually Due to Medication Non-Adherence
2. Global Display Market Worth $164.24 Billion by 2017
3. Global Heparin Market 2011-2015: MarketResearchReports.Biz
4. Global Pharmaceuticals & Medicine Manufacturing
5. Echo Therapeutics Hires Daniel Sunday as Vice President of Manufacturing and Global Supply Chain
6. Active Pharmaceutical Ingredients (API) Global Market to 2017 - Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand
7. Clinical Trial Strategies to Ensure Pharmaceutical Success in a Global Marketplace
8. Global Market for Disposable Medical Supplies To Reach Nearly $200 Billion in 2016
9. Janssen Research & Development Announces Establishment of Global Cross-Pharmaceutical Clinical Trial Investigator Databank
10. Global and China Industrial Enzyme Industry Report, 2012-2014
11. Global Ostomy Drainage Bags Market is Expected to Reach USD 2.6 Billion in 2018: Transparency Market Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... 24, 2017 ShangPharma, a leading ... cost-effective drug development and discovery services, technology, ... industry, announced today the intent for a ... be consolidating the Contract Research Organizations (CRO) ... ChemPartner. These entities include ChemPartner Shanghai, ChemPartner ...
(Date:3/24/2017)... Research and Markets has announced the addition of the "Global ... ... very strong with a total of 97 drug candidates. Pharma giant such ... involved in the development of the IPF therapeutics. The IPF pipeline comprised ... 15 are in Phase II stage, 12 are in Phase I stage, ...
(Date:3/24/2017)... -- Global Ampoules Market report provides a ... and industry chain structure. The Ampoules market analysis is ... landscape analysis, and major regions, development status. ... Complete ... 10 company profiles and 183 tables and figures is ...
Breaking Medicine Technology:
(Date:3/23/2017)... , ... March 23, 2017 , ... ... services to their communities, 16 more public health departments have been awarded national ... bring another 4.5 million people into the expanding network of communities across the ...
(Date:3/23/2017)... Minneapolis, MN (PRWEB) , ... March 23, 2017 , ... ... with internet and WiFi connectivity are making a huge impact on businesses and individual ... Global Institute estimates the IoT will have a value anywhere from $4 trillion to ...
(Date:3/23/2017)... (PRWEB) , ... March 23, ... ... and financial services firm serving the families and businesses of the Norwalk ... enrichment program. Northern Ohio Recovery Center (N.O.R.A.) is a nonprofit, community-based substance ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... Management Accreditation from the NCQA. The accreditation covers StayWell’s asthma, coronary artery disease, ... status is granted to organizations that have excellent programs for the delivery and ...
(Date:3/23/2017)... Scottsdale, AZ (PRWEB) , ... March 23, 2017 , ... ... helping people around the world to manage stress and anxiety. , “Buzzies change ... Serin, neuropsychologist, inventor and co-founder of Buzzies. , Since its launch date in December ...
Breaking Medicine News(10 mins):